Dokter Paru Malang
Dokter Paru Malang
Apotek Respirasi Klinik Respirasi Malang
Berita Kesehatan
Acute effects of 50?mg additive oral sildenafil on invasive exercise hemodynamics in pulmonary vascular disease
Selasa, 08 Apr 2025 16:53:51

Abstract

Background and aims

Patients with precapillary pulmonary hypertension (PH) due to pulmonary vascular disease (PVD) have reduced exercise capacity, limiting daily activity and quality of life. Phospodiesterase-5 inhibitors including sildenafil are used to treat PVD. This study examined effects of sildenafil on pulmonary hemodynamics during exercise in PVD.

Method

PVD-patients diagnosed as pulmonary arterial or chronic thromboembolic PH (PAH/CTEPH) underwent right heart catheterization assessed at rest and during mild exercise. Main outcomes were mean pulmonary artery pressure (mPAP), cardiac output (CO) and mPAP/CO-slope before and ?60?min after additive sildenafil (50?mg oral).

Results

22 PVD-patients (14 PAH, 8 CTEPH, 9 women, 15 pretreated (9 combination therapy)) with a mean±sd age 54±14?years, mPAP 39±10?mmHg, CO 4.7±1.5?l·min?1 and pulmonary vascular resistance 6.9±3.8 WU were included. After sildenafil, mPAP and CO at rest were unchanged, but at end-exercise, mPAP and mPAP/CO slope significantly decreased (mPAP 61±16 versus 54±16?mmHg; mean difference (95% CI) ?7 (?11 to ?4), p<0.001 and mPAP/CO-slope 9.8±4.9 versus 6.6±3.3; ?3(?4.9 to ?1.2) p=0.002).

The mean systemic arterial pressure was significantly lower after additive sildenafil at rest (?9 (?13 to ?5, p<0.001)) mmHg and at end-exercise (?9(?13 to ?5, p<0.001)) mmHg. One patient experienced dizziness.